Key precautions for safe use of phenobarbital sodium for injection (Sezaby)

Phenobarbital sodium for injection, as the leader among barbiturates, plays a pivotal role in the treatment of epileptic seizures in term and premature infants. However, its use must strictly follow professional guidance to ensure patient safety. The following is a detailed explanation of contraindications and key issues that require special attention when using this drug.

1. Clear contraindications

First, injectable phenobarbital sodium is absolutely contraindicated in patients with acute porphyria. This is because the drug may worsen the symptoms of porphyria or even cause more serious health problems. In addition, use should also be strictly contraindicated in patients with allergic reactions to phenobarbital sodium or other barbiturates. Anaphylaxis may manifest as rashes, difficulty breathing, and may even be life-threatening in severe cases.

2. Be wary of physical dependence

Prolonged or repeated use of phenobarbital sodium for injection may cause the body to become dependent on it. This state of dependence may trigger withdrawal symptoms, such as epileptic seizures, when the drug is suddenly stopped or the dose is significantly reduced. Therefore, patients receiving higher doses or using this drug for prolonged periods should be cautious when discontinuing or reducing the dose to avoid triggering acute withdrawal reactions. Medical staff should pay close attention to the patient's response and adjust the treatment plan according to the actual situation.

3. Strict requirements for storage conditions

The storage conditions of phenobarbital sodium for injection cannot be ignored. Unopened vials should be stored in the original carton at 20°C to 25°C (68°F to 77°F), allowing brief drift between 15°C and 30°C (59°F and 86°F). Before use, it should be kept in the original carton to protect it from light to prevent the drug from being degraded by light. For reconstituted solutions, if not used immediately, return them to their original packaging, protect from light, and store at room temperature (20°C to 25°C, 68°F to 77°F) for a maximum of 8 hours, or in the refrigerator (2°C to 8°C, 36°F to 46°F) for a maximum of 24 hours. Unused portions of the reconstituted solution that have exceeded the recommended storage period should be discarded to ensure the safety and effectiveness of the medication.

In summary, phenobarbital sodium for injection plays an important role in the treatment of epileptic seizures, but its use must strictly follow professional guidance and pay attention to key matters such as contraindications, risk of physical dependence, and storage conditions. Compliance with these precautions is crucial to ensuring patient medication safety and therapeutic efficacy. Healthcare professionals should fully understand and follow these guidelines to ensure patients receive safe and effective treatment.

Reference: https://www.drugs.com/pro/sezaby-injection.html